 |
|
|
| |
Frequency and impact of potential multiple
drug-drug interactions (DDIs) associated with
pangenotypic direct-acting antivirals in patients
receiving opioid substitution therapy
|
| |
| |
EASL International Liver Congress, June 23-26, 2021
F. Tacke1, G. Niess2, M. Gündogdu2, A. Hintz3, T. Umland3
Charite - Universitatsmedizin Berlin, Department of Hepatology and Gastroenterology, Berlin, Germany, 2Gilead Sciences GmbH, Martinsried / Munich, Germany; 3Alexander Apotheke, Hamburg, Germany
|
| |
|
|
|
|
|
